FutraMed
Curated by SignalTranscutaneous electrical cranial stimulator to reduce opioid dependence in chronic pain patients
Overview
FutraMed has developed a patented battery powered medical device, a transcutaneous electrical cranial stimulator to reduce opioid consumption and dependence in the treatment of chronic pain. Limoge Current creates an analgesic effect and potentiates or enhances the effectiveness of the treatment drug being used by the chronic pain patient. As of July 2016 the Limoge device is going through the final stages of regulatory approvals necessary to receive the CE mark in order to begin selling in Europe
Key facts
- Founded
- 2012
- Headquarters
- Orem, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view